Department of Medical Affairs & Pharmacovigilance • Clinical Formulary Monograph
D 92/6 Okhla Phase 1, New Delhi, 110020, India • Medical Helpline: +91 11-47532297 • Email: contact@vrmedhealthcare.com
Etoversa-60
Selective COX-2 Inhibitor for Joint & Musculoskeletal Pain
Etoversa-60
Selective COX-2 Inhibitor for Joint & Musculoskeletal Pain
Etoricoxib Tablets IP 60mg
Product Clinical Overview
Etoversa-60 contains Etoricoxib 60mg, an orally active selective cyclooxygenase-2 (COX-2) inhibitor belonging to the dipyridyl class of NSAIDs. It is indicated for the symptomatic relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal conditions.
More Images
Actual Etoversa-60 packaging, label panels and blister strip.
Key Ingredients & Pharmacological Profiles
Active chemical constituents, standardized strengths, and physiological roles.
Selective inhibitor of cyclooxygenase-2 (COX-2) enzyme suppressing pro-inflammatory prostaglandins.
Approved Clinical Indications
Clinical contexts where this formulation is prescribed under medical supervision.
Pharmacological Mechanism of Action
Etoricoxib inhibits the conversion of arachidonic acid to inflammatory prostaglandins (PGE2, PGF2a) through selective inhibition of the COX-2 enzyme at sites of tissue inflammation.
Formulation & Delivery Technology
- Extended plasma half-life (~22 hours) supporting convenient once-daily dosing
- Maintains gastric mucosal COX-1 prostaglandin synthesis
- Rapid oral absorption with high absolute bioavailability
VR Med Healthcare Pvt. Ltd.
Registered Office & Facility:D 92/6 Okhla Phase 1, New Delhi, 110020, India
Quality Certifications:WHO-GMP Compliant & ISO 9001:2015 Certified
Medical Helpline:+91 11-47532297
Corporate Email:contact@vrmedhealthcare.com
Administration & Packaging Details
60 mg once daily with water, with or without food, as advised by a Physician.
10 x 10 Tablets (Blister Strip)
Store in the original package in order to protect from moisture. Do not store above 30°C.
This formulation monograph is published strictly for the professional scientific reference and educational use of Registered Medical Practitioners, Hospitals, and Clinical Laboratories. The technical and pharmacological details presented herein do not constitute medical advice, diagnostic opinion, or therapeutic claims. These products must be prescribed, dispensed, and administered strictly in accordance with local drug regulations and under the supervision of a licensed physician. VR Med Healthcare Pvt. Ltd. does not promote self-medication, off-label usage, or unsolicited consumer health claims.
More in Pain & Muscle
Etoversa-MR
Targeted COX-2 Inhibitor & Spasmolytic Muscle Relaxant
Tremasine
Centrally Acting Opioid & Analgesic-Antipyretic Combination
Vibanuron
Pregabalin with Methylcobalamin Neuropathic Pain Formulation
Enhancing Lives With
Quality Healthcare & Integrity.
VR Med Healthcare has been a trusted benchmark in the Indian pharmaceutical sector since 2010. Headquartered in Okhla Phase 1, New Delhi, our dedicated team of over 100 professionals collaborates with leading physicians and distributors across India to make premium medicines accessible and reliable.
“Our goal is to deliver quality of care in a courteous, respectful, and compassionate manner. We hope you will allow us to care for you and strive to be the first and best choice for healthcare professionals and families.”
Kamal Choudhary
Managing Director, VR Med Healthcare
Established
Approved Formulations
Healthcare Specialists
Manufacturing Standard